Table of Contents:
  • v. 1. Mechanistic approaches to cancer.
  • Mechanisms of chemical carcinogenesis and molecular parametric analysis in the safety evaluation of chemicals
  • Metabolic generation of reactive intermediates
  • The use of computers in evaluating the toxicity and carcinogenicity of chemicals
  • Safety evaluation in the twenty-first century
  • Reactive oxygen species in the aetiology of cancer
  • ROS and chemical carcinogenesis
  • Prospects for the future
  • Carcinogens formed during cooking
  • Isolation and chemical structure
  • Formation
  • Quantitation
  • Genotoxicity
  • Metabolism
  • Binding to macromolecules
  • Carcinogenicity
  • Human significance
  • Teratogenicity of pharmaceutical agents established as having carcinogenic effects: Review of effects and mechanisms
  • Pharmaceutical agents recognized as carcinogenic.
  • Sources of information on teratogenic effects
  • Classification of evidence as to teratogenicity
  • Review of possible teratogenic effects: Antineoplastic drugs
  • Review of possible teratogenic effects: Hormonal preparations
  • Review of possible teratogenic effects: Immunosuppressants
  • Review of possible teratogenic effects: Analgesic mixtures containing phenacetin
  • Mechanistic considerations
  • Discussion and conclusion
  • Mechanisms of anticarcinogenesis: The example of N-acetylcysteine
  • Chemoprevention of cancer and other mutation-related diseases
  • Mechanisms of inhibition of carcinogenesis, with special reference to N-acetylcysteine
  • N-acetylcysteine: Biochemical and pharmacological issues
  • Protective effects and mechanisms of N-acetylcysteine, as assessed in in vitro test systems
  • Protective effects and mechanisms of N-acetylcysteine, as assessed in animal models
  • Clinical trials in humans.
  • Immunotherapy of cancer: Monoclonal antibodies
  • Production of monoclonal antibodies
  • Antibody structure and function
  • General applications of monoclonal antibodies
  • Monoclonal antibodies and cancer
  • Monoclonal antibodies in diagnosis of cancer
  • Monoclonal antibodies in therapy of cancer
  • Antibody immunogenicity/ humanized antibodies
  • Single chain antibodies
  • Cancer genetics
  • Phase I enzymes
  • Phase II enzymes
  • Combined polymorphisms
  • Other genes involved in carcinogen metabolism
  • Discussion
  • Is folic acid pluripotent?
  • Characteristics and sources of folic acid
  • Consequences of frank deficiency
  • Neural tube defects
  • Other congenital anomalies
  • Cancer
  • Folate and other diseases
  • Discussion and conclusions.